Clinical Trials Logo

Ventricular Premature Complexes clinical trials

View clinical trials related to Ventricular Premature Complexes.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03867747 Active, not recruiting - Clinical trials for Ventricular Tachycardia

Radiosurgery for the Treatment of Refractory Ventricular Extrasystoles and Tachycardias

RAVENTA
Start date: December 2, 2019
Phase: N/A
Study type: Interventional

Patients with refractory ventricular extrasystoles or tachycardia not eligible for catheter ablation will receive single fraction stereotactic body radiation therapy (cardiac radiosurgery) with 25 Gy. Investigators initiated this study to demonstrate that in at least 70% of the patients the planned cardiac radiosurgery may be performed without any interruption or treatment related interventional events within the first 30 days after treatment.

NCT ID: NCT03228823 Active, not recruiting - Cardiomyopathies Clinical Trials

Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)

PAPS
Start date: August 1, 2018
Phase: Phase 4
Study type: Interventional

Premature ventricular contractions (PVCs) coexist in patients with heart failure (HF) and LV dysfunction. Frequent PVCs have shown to induce a reversible cardiomyopathy (PVC-CM). This clinical pilot study will enroll 36 patients with frequent PVCs (burden >10%) and CM (LVEF <45%) and randomize them to either: 1) RFA or 2) AADs. Prior to treatment, patients will undergo a baseline cardiac MR if clinically indicated followed by 3-month observation period (optimal HF medical therapy). Changes in LV function/scar, PVC burden/arrhythmias and clinical/functional status (QOL, HF symptoms and admissions, NYHA class) and adverse events will be assessed throughout the observation period and compare with PVC suppression strategies (RFA or AAD). Similar comparison will be made between RFA and AAD treatment groups during a 12-month follow up using a Prospective Randomized Open, Blinded End-point (PROBE) study design. The treatment regimens will be compared in an intention-to-treat analysis. In addition, a total of 20,000 consecutive ambulatory ECG Holter monitors from all participating centers will be screened to identify all patients with probable diagnosis of PVC-CM. This pilot study is intended to estimate the prevalence of this clinical entity and pave the way for a large full scale randomized trial to identify best treatment strategy for patients with PVC-CM. Treating and reversing this underestimated PVC-CM may improve patient's health and subsequently decrease HF healthcare spending.

NCT ID: NCT02919618 Active, not recruiting - Clinical trials for Ventricular Tachycardia

Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia

ENCORE-VT
Start date: July 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation (ENCORE) for Treatment of Ventricular Tachycardia